Bliss GVS Pharma expands international footprint with new Kenya subsidiary

Bliss GVS Pharma Limited announced on November 25, 2025, the incorporation of Theralife Pharma Ltd in Nairobi, Kenya. This new entity is a wholly owned subsidiary of Bliss GVS International PTE Ltd, Singapore, which is itself a wholly owned subsidiary of Bliss GVS Pharma Limited.

Theralife Pharma Ltd was incorporated on November 24, 2025, in Kenya, and operates within the pharmaceutical and healthcare industry. The new subsidiary has a share capital of KES 100, represented by 1,000 ordinary shares, and is 100% shareholding by Bliss International PTE Ltd.

As an incorporation rather than an acquisition, details regarding turnover for the last three years are not applicable. The company states that the incorporation is not a related party transaction and is not expected to fall under conditions requiring specific governmental or regulatory approvals beyond standard incorporation procedures.